Human Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) Protein
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Human Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) Protein is a recombinant protein from Human produced in E. coli. A DNA sequence encoding the human Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) (P14550) (Met 1-Tyr 325) was expressed, with a polyhistidine tag at the N-terminus.
Documents del producto
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) |
| Host | E. coli |
| Origin | Human |
| Observed MW | Molecular Weight: 39 kDa Sequence Fragment: Met1-Tyr325 Tag: N-terminal His tag Validity: The validity for this protein is 12 months. |
| Expression | Recombinant |
| Purity | > 90% (SDS-PAGE) |
| Size 1 | 100 µg |
| Form | |
| Tested Applications | SDS-PAGE |
| Buffer | Lyophilized from sterile PBS, pH 7.5. |
| Availability | Shipped within 5-15 working days. |
| Storage | Aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P14550 |
| Alias | AKR1A1, ALDR1, ALR,ARM, DD3 |
| Background | Protein AKR1A1 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
AKR1A1 is a widely expressed enzyme that belongs to the aldo-keto reductase superfamily. It catalyzes the reduction of aldehydes and ketones to their respective alcohols using NADPH as a cofactor, playing a key role in detoxifying reactive aldehydes generated during lipid peroxidation and metabolism. AKR1A1 is involved in the metabolism of endogenous compounds, such as prostaglandins, steroids, and lipid-derived aldehydes, as well as exogenous toxins, including chemotherapeutics and environmental pollutants. AKR1A1 has significant antioxidant properties due to its ability to reduce harmful aldehydes, thus protecting cells from oxidative stress. It also contributes to glucose metabolism by participating in the sorbitol pathway, particularly in the liver, kidneys, and lens. Dysregulation of AKR1A1 is implicated in metabolic disorders, including diabetic complications, cataract formation, and cardiovascular diseases. Additionally, AKR1A1 has been shown to play a role in drug resistance by metabolizing chemotherapeutic agents, making it a target for improving cancer treatments.
Related Products
anti- AKR1A1 antibody
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member, also known as aldehyde reductase, is involved in the reduction of biogenic and xenobiotic aldehydes and is present in virtually every tissue. Multiple alternatively spliced transcript variants of this gene exist, all encoding the same protein.
Ver Producto
Recombinant Human AKR1A1
Ver Producto
Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) Antibody
Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) Antibody is a Rabbit Polyclonal antibody against Aldo-Keto Reductase Family 1 Member A1 (AKR1A1). This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member, also known as aldehyde reductase, is involved in the reduction of biogenic and xenobiotic aldehydes and is present in virtually every tissue. Multiple alternatively spliced transcript variants of this gene exist, all encoding the same protein. [provided by RefSeq, Jan 2011].
Ver Producto